{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:36:55Z","timestamp":1787665015010,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07768-0","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T06:53:59Z","timestamp":1770188039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["EP300 promotes hepatocellular carcinoma proliferation, migration and in vivo tumorigenicity revealed by integrated experimental and bioinformatic analyses"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhipeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youming","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"7768_CR1","doi-asserted-by":"publisher","unstructured":"Dai Y, Wang H, Wang W, Zhuang X. Multidimensional pan cancer analysis of the sodium induced cell death gene TRPM4. Sci Rep. 2025;15(1):29768. https:\/\/doi.org\/10.1038\/s41598-025-15082-w","DOI":"10.1038\/s41598-025-15082-w"},{"key":"7768_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"7768_CR3","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1097\/cm9.0000000000003264","volume":"137","author":"Q Li","year":"2024","unstructured":"Li Q, et al. Global epidemiology of liver cancer 2022: an emphasis on geographic disparities. Chin Med J (Engl). 2024;137:2334\u201342. https:\/\/doi.org\/10.1097\/cm9.0000000000003264.","journal-title":"Chin Med J (Engl)"},{"key":"7768_CR4","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/hep.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal AG, et al. AASLD Practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78:1922\u201365. https:\/\/doi.org\/10.1097\/hep.0000000000000466.","journal-title":"Hepatology"},{"key":"7768_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma","year":"2018","unstructured":"EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69:182\u2013236. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.019.","journal-title":"J Hepatol"},{"key":"7768_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378\u201390. https:\/\/doi.org\/10.1056\/NEJMoa0708857.","journal-title":"N Engl J Med"},{"key":"7768_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/157488512800389164","volume":"7","author":"A Imran","year":"2012","unstructured":"Imran A, Waseem AW, Kishwar S, Ashanul H. Thalidomide: a banned Drug resurged into future Anticancer Drug. Curr Drug Ther. 2012;7:13\u201323. https:\/\/doi.org\/10.2174\/157488512800389164.","journal-title":"Curr Drug Ther"},{"key":"7768_CR8","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.2174\/0929867323666160405111152","volume":"23","author":"I Ali","year":"2016","unstructured":"Ali I, Lone MN, Suhail M, Mukhtar SD, Asnin L. Advances in nanocarriers for Anticancer drugs delivery. Curr Med Chem. 2016;23:2159\u201387. https:\/\/doi.org\/10.2174\/0929867323666160405111152.","journal-title":"Curr Med Chem"},{"key":"7768_CR9","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1101\/gad.14.13.1553","volume":"14","author":"RH Goodman","year":"2000","unstructured":"Goodman RH, Smolik S. CBP\/p300 in cell growth, transformation, and development. Genes Dev. 2000;14:1553\u201377.","journal-title":"Genes Dev"},{"key":"7768_CR10","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1021\/cr500452k","volume":"115","author":"BM Dancy","year":"2015","unstructured":"Dancy BM, Cole PA. Protein lysine acetylation by p300\/CBP. Chem Rev. 2015;115:2419\u201352. https:\/\/doi.org\/10.1021\/cr500452k.","journal-title":"Chem Rev"},{"key":"7768_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nature24028","volume":"550","author":"LM Lasko","year":"2017","unstructured":"Lasko LM, et al. Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours. Nature. 2017;550:128\u201332. https:\/\/doi.org\/10.1038\/nature24028.","journal-title":"Nature"},{"key":"7768_CR12","doi-asserted-by":"publisher","first-page":"8889","DOI":"10.1021\/acs.jmedchem.6b00774","volume":"59","author":"TA Popp","year":"2016","unstructured":"Popp TA, et al. Development of selective CBP\/P300 benzoxazepine bromodomain inhibitors. J Med Chem. 2016;59:8889\u2013912. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00774.","journal-title":"J Med Chem"},{"key":"7768_CR13","doi-asserted-by":"publisher","unstructured":"Cui SY, et al. The role of Aurora a in hypoxia-inducible factor 1\u03b1-promoting malignant phenotypes of hepatocelluar carcinoma. Cell Cycle. 2013;12:2849\u201366. https:\/\/doi.org\/10.4161\/cc.25916.","DOI":"10.4161\/cc.25916"},{"key":"7768_CR14","doi-asserted-by":"publisher","unstructured":"Llovet JM, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(6). https:\/\/doi.org\/10.1038\/s41572-020-00240-3.","DOI":"10.1038\/s41572-020-00240-3"},{"key":"7768_CR15","doi-asserted-by":"publisher","unstructured":"Conesa A, et al. A survey of best practices for RNA-seq data analysis. Genome Biol. 2016;17(13). https:\/\/doi.org\/10.1186\/s13059-016-0881-8.","DOI":"10.1186\/s13059-016-0881-8"},{"key":"7768_CR16","doi-asserted-by":"publisher","unstructured":"Colaprico A, et al. Tcgabiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44:e71. https:\/\/doi.org\/10.1093\/nar\/gkv1507.","DOI":"10.1093\/nar\/gkv1507"},{"key":"7768_CR17","doi-asserted-by":"publisher","unstructured":"Deng X, Thompson J. An R package for survival-based gene set enrichment analysis. PeerJ. 2025;13:e19489. https:\/\/doi.org\/10.7717\/peerj.19489.","DOI":"10.7717\/peerj.19489"},{"key":"7768_CR18","doi-asserted-by":"publisher","unstructured":"Chandrashekar DS, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19:649\u201358. https:\/\/doi.org\/10.1016\/j.neo.2017.05.002.","DOI":"10.1016\/j.neo.2017.05.002"},{"key":"7768_CR19","doi-asserted-by":"publisher","unstructured":"Nagy \u00c1, Munk\u00e1csy G, Gy\u0151rffy B. Pancancer survival analysis of cancer hallmark genes. Sci Rep. 2021;11:6047. https:\/\/doi.org\/10.1038\/s41598-021-84787-5.","DOI":"10.1038\/s41598-021-84787-5"},{"key":"7768_CR20","doi-asserted-by":"publisher","unstructured":"Li T, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509\u2013w514. https:\/\/doi.org\/10.1093\/nar\/gkaa407.","DOI":"10.1093\/nar\/gkaa407"},{"key":"7768_CR21","doi-asserted-by":"publisher","unstructured":"Hao Y, Yan M, Heath BR, Lei YL, Xie Y. Fast and robust deconvolution of tumor infiltrating lymphocyte from expression profiles using least trimmed squares. PLoS Comput Biol. 2019;15:e1006976. https:\/\/doi.org\/10.1371\/journal.pcbi.1006976.","DOI":"10.1371\/journal.pcbi.1006976"},{"key":"7768_CR22","doi-asserted-by":"publisher","unstructured":"Szklarczyk D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607\u2013d613. https:\/\/doi.org\/10.1093\/nar\/gky1131.","DOI":"10.1093\/nar\/gky1131"},{"key":"7768_CR23","doi-asserted-by":"publisher","unstructured":"Shannon P, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504. https:\/\/doi.org\/10.1101\/gr.1239303.","DOI":"10.1101\/gr.1239303"},{"key":"7768_CR24","doi-asserted-by":"publisher","unstructured":"Wu T, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2:100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141.","DOI":"10.1016\/j.xinn.2021.100141"},{"key":"7768_CR25","doi-asserted-by":"publisher","unstructured":"Liberzon A, et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417\u201325. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004.","DOI":"10.1016\/j.cels.2015.12.004"},{"key":"7768_CR26","doi-asserted-by":"publisher","unstructured":"Chi CM, Fan Y, Ing CK, Lv J. High-dimensional knockoffs inference for Time series data. J Am Stat Assoc. 2025. https:\/\/doi.org\/10.1080\/01621459.2024.2431344.","DOI":"10.1080\/01621459.2024.2431344"},{"key":"7768_CR27","doi-asserted-by":"publisher","unstructured":"Matei M, et al. Preoperative expression profiles of miR-146a and miR-221 as potential biomarkers for differentiating benign from malignant thyroid nodules. Int J Mol Sci. 2025;26. https:\/\/doi.org\/10.3390\/ijms26157564.","DOI":"10.3390\/ijms26157564"},{"key":"7768_CR28","doi-asserted-by":"publisher","unstructured":"Bustin SA, et al. MIQE 2.0: revision of the minimum Information for publication of quantitative real-Time PCR experiments guidelines. Clin Chem. 2025. https:\/\/doi.org\/10.1093\/clinchem\/hvaf043.","DOI":"10.1093\/clinchem\/hvaf043"},{"key":"7768_CR29","doi-asserted-by":"publisher","unstructured":"Taylor SC, Posch A. The design of a quantitative western blot experiment. Biomed Res Int. 2014;2014:361590. https:\/\/doi.org\/10.1155\/2014\/361590.","DOI":"10.1155\/2014\/361590"},{"key":"7768_CR30","doi-asserted-by":"publisher","unstructured":"Gilda JE, Gomes AV. Stain-free total protein staining is a superior loading control to \u03b2-actin for Western blots. Anal Biochem. 2013;440:186\u201388. https:\/\/doi.org\/10.1016\/j.ab.2013.05.027.","DOI":"10.1016\/j.ab.2013.05.027"},{"key":"7768_CR31","doi-asserted-by":"publisher","unstructured":"Shoukair DH, et al. Identification of neuro-inflammatory biomarkers through non-invasive advanced neuroimaging techniques in pharmaco-resistant epilepsy: a systematic review. Epilepsy Behav. 2025;171:110641. https:\/\/doi.org\/10.1016\/j.yebeh.2025.110641.","DOI":"10.1016\/j.yebeh.2025.110641"},{"key":"7768_CR32","doi-asserted-by":"publisher","unstructured":"Kikuchi M, et al. Epigenetic mechanisms to propagate histone acetylation by p300\/CBP. Nat Commun. 2023;14:4103. https:\/\/doi.org\/10.1038\/s41467-023-39735-4.","DOI":"10.1038\/s41467-023-39735-4"},{"key":"7768_CR33","doi-asserted-by":"publisher","unstructured":"Whyte WA, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153:307\u201319. https:\/\/doi.org\/10.1016\/j.cell.2013.03.035.","DOI":"10.1016\/j.cell.2013.03.035"},{"key":"7768_CR34","doi-asserted-by":"publisher","unstructured":"Visel A, et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature. 2009;457:854\u201358. https:\/\/doi.org\/10.1038\/nature07730.","DOI":"10.1038\/nature07730"},{"key":"7768_CR35","doi-asserted-by":"publisher","unstructured":"Ali I, Wani WA, Saleem K, Wesselinova DS. DNA binding and Anticancer profiles of L-Glutamic acid ligand and its Copper(II) and Ruthenium(III) complexes. Med Chem. 2013;9:11\u201321. https:\/\/doi.org\/10.2174\/157340613804488297.","DOI":"10.2174\/157340613804488297"},{"key":"7768_CR36","doi-asserted-by":"publisher","unstructured":"Masci D, Puxeddu M, Silvestri R, La Regina G. Targeting CBP and p300: emerging Anticancer agents. Molecules. 2024;29. https:\/\/doi.org\/10.3390\/molecules29194524.","DOI":"10.3390\/molecules29194524"},{"key":"7768_CR37","doi-asserted-by":"publisher","unstructured":"Cai LY, et al. Targeting p300\/CBP attenuates hepatocellular carcinoma progression through epigenetic regulation of metabolism. Cancer Res. 2021;81:860\u201372. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-1323.","DOI":"10.1158\/0008-5472.Can-20-1323"},{"key":"7768_CR38","doi-asserted-by":"publisher","unstructured":"Ma C, et al. Transcription co-activator P300 activates Elk1-aPKC-\u03b9 signaling mediated epithelial-to-mesenchymal transition and malignancy in hepatocellular carcinoma. Oncogenesis. 2020;9(32). https:\/\/doi.org\/10.1038\/s41389-020-0212-5.","DOI":"10.1038\/s41389-020-0212-5"},{"key":"7768_CR39","doi-asserted-by":"publisher","unstructured":"Lambin P, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14:749\u201362. https:\/\/doi.org\/10.1038\/nrclinonc.2017.141.","DOI":"10.1038\/nrclinonc.2017.141"},{"key":"7768_CR40","doi-asserted-by":"publisher","unstructured":"Zhao Z, Ding F, Zhang Z. Epigenetic silencing of SFRP5 promotes hepatocellular carcinoma progression and metastasis via Wnt\/\u03b2-catenin signaling. Apmis. 2025;133:e70060. https:\/\/doi.org\/10.1111\/apm.70060.","DOI":"10.1111\/apm.70060"},{"key":"7768_CR41","doi-asserted-by":"publisher","unstructured":"Yu F, et al. Wnt\/\u03b2-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther. 2021;6:307. https:\/\/doi.org\/10.1038\/s41392-021-00701-5.","DOI":"10.1038\/s41392-021-00701-5"},{"key":"7768_CR42","doi-asserted-by":"publisher","unstructured":"Li S, Shi J, Wang L, Zhang D, Zhang H. EP300 promotes lung cancer cell proliferation by regulating the oncogenic transcription of hippo-YAP signaling pathway. Biochem Biophys Res Commun. 2024;692:149330. https:\/\/doi.org\/10.1016\/j.bbrc.2023.149330.","DOI":"10.1016\/j.bbrc.2023.149330"},{"key":"7768_CR43","doi-asserted-by":"publisher","unstructured":"Liu J, et al. Therapeutic targeting of the p300\/CBP bromodomain enhances the efficacy of immune checkpoint blockade therapy. Oncogene. 2025;44:2386\u201395. https:\/\/doi.org\/10.1038\/s41388-025-03417-w.","DOI":"10.1038\/s41388-025-03417-w"},{"key":"7768_CR44","doi-asserted-by":"publisher","unstructured":"Eftekhari A, Sabir U, Kasumov T. The role of lysine acetylation in metabolic sensing and proteostasis. Pharmacol Ther. 2025;274:108908. https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108908.","DOI":"10.1016\/j.pharmthera.2025.108908"},{"key":"7768_CR45","doi-asserted-by":"publisher","unstructured":"Pietrocola F, et al. Spermidine induces autophagy by inhibiting the acetyltransferase EP300. Cell Death Differ. 2015;22:509\u201316. https:\/\/doi.org\/10.1038\/cdd.2014.215.","DOI":"10.1038\/cdd.2014.215"},{"key":"7768_CR46","doi-asserted-by":"publisher","unstructured":"Wu W, et al. P300\/HDAC1 regulates the acetylation\/deacetylation and autophagic activities of LC3\/Atg8-PE ubiquitin-like system. Cell Death Discov. 2021;7:128. https:\/\/doi.org\/10.1038\/s41420-021-00513-0.","DOI":"10.1038\/s41420-021-00513-0"},{"key":"7768_CR47","doi-asserted-by":"publisher","unstructured":"Hu Y, et al. Lactylation: the novel histone modification influence on gene expression, protein function, and disease. Clin Epigenet. 2024;16(72). https:\/\/doi.org\/10.1186\/s13148-024-01682-2.","DOI":"10.1186\/s13148-024-01682-2"},{"key":"7768_CR48","doi-asserted-by":"publisher","unstructured":"Lu Z, et al. Lactylation: the emerging frontier in post-translational modification. Front Genet. 2024;15:1423213. https:\/\/doi.org\/10.3389\/fgene.2024.1423213.","DOI":"10.3389\/fgene.2024.1423213"},{"key":"7768_CR49","doi-asserted-by":"publisher","unstructured":"Xie Y, et al. The role and mechanism of histone lactylation in health and diseases. Front Genet. 2022;13:949252. https:\/\/doi.org\/10.3389\/fgene.2022.949252.","DOI":"10.3389\/fgene.2022.949252"},{"key":"7768_CR50","doi-asserted-by":"publisher","unstructured":"Wang K, Baird L, Yamamoto M. The clinical-grade CBP\/p300 inhibitor CCS1477 represses the global NRF2-dependent cytoprotective transcription program and re-sensitizes cancer cells to chemotherapeutic drugs. Free Radic Biol Med. 2025;233:102\u201317. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.03.034.","DOI":"10.1016\/j.freeradbiomed.2025.03.034"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07768-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07768-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07768-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:04:51Z","timestamp":1772795091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07768-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7768"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07768-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving human tissues and animal experiments complied with relevant guidelines and regulations. Human RT-qPCR validation on paired hepatocellular carcinoma (HCC) tumor and adjacent tissues was approved by the Institutional Review Board of The First Rehabilitation Hospital of Shandong Province (Approval No. DW2025001), and written informed consent was obtained from all participants in accordance with the Declaration of Helsinki (2013). All animal procedures (subcutaneous xenografts in BALB\/c nude mice) were approved by the Institutional Animal Care and Use Committee of The First Rehabilitation Hospital of Shandong Province (Approval No. DW2025001) and adhered to ARRIVE 2.0 guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. The manuscript does not include any individual person\u2019s data (including images or videos) requiring consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"329"}}